Evidence map›Paper›PMID 23835587›Full record

ArticleInternational journal of oncology2013

Effects of combined phytochemicals on skin tumorigenesis in SENCAR mice.

Magdalena C Kowalczyk, Jacob J Junco, Piotr Kowalczyk, Olga Tolstykh, Margaret Hanausek, Thomas J Slaga, Zbigniew Walaszek

Open access · bronzeAbstract read
In one paragraph

Article in International journal of oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. The Role of Resveratrol in Cancer Therapy.International journal of molecular sciences · 2017
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Magdalena C KowalczykDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Jacob J Junco
Piotr Kowalczyk
Olga Tolstykh
Margaret Hanausek
Thomas J Slaga
Zbigniew Walaszek
The University of Texas Health Science Center at San Antonio · US

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Lei Zheng · 1991 to 2026
$59.1M
Combined Natural Inhibitors in Skin Cancer PreventionR01CA102747 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SLAGA, THOMAS J · 2003 to 2007
$1.9M
NCI NIH HHS P30 CA 54174-1651NCI NIH HHS R01 CA 102747NCI NIH HHS R01 CA102747
6 · The paper itself

Abstract

The purpose of our study was to determine the effect of the combined action of phytochemicals on the early stages of skin tumorigenesis, i.e. initiation and promotion. We tested calcium D-glucarate (CG) given in the diet, while resveratrol (RES) and ursolic acid (UA) were applied topically. The 7,12-dimethylbenz[a]anthracene (DMBA)-initiated, 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted multistage skin carcinogenesis model in SENCAR mice was used. Mice received one topical dose of DMBA, then after one month, two weekly doses of TPA for 14 weeks until sacrifice. RES or UA were applied 20 min prior to DMBA or TPA treatment and 2% dietary CG was given from 2 weeks prior to 2 weeks after the DMBA dose or continually beginning 2 weeks prior to the first dose of TPA. UA applied alone and in combination with CG during the promotion stage was the only inhibitor of tumor multiplicity and tumor incidence. A number of combinations reduced epidermal proliferation, but only UA and the combination UA+CG applied during promotion significantly reduced epidermal hyperplasia. DMBA/TPA application resulted in significant increases in c-jun and p50, which were reversed by a number of different treatments. DMBA/TPA treatment also strongly increased mRNA levels of inflammation markers COX-2 and IL-6. All anti-promotion treatments caused a marked decrease in COX-2 and IL-6 expression compared to the DMBA/TPA control. These results show that UA is a potent inhibitor of skin tumor promotion and inflammatory signaling and it may be useful in the prevention of skin cancer and other epithelial cancers in humans.

Indexed as

9,10-Dimethyl-1,2-benzanthraceneAnimalsCarcinogenesisCell ProliferationCyclooxygenase 2FemaleGene Expression Regulation, NeoplasticGlucaric AcidHumansInterleukin-6MiceMice, Inbred SENCARPhytochemicalsResveratrolSkin NeoplasmsStilbenes9,10-Dimethyl-1,2-benzanthraceneCyclooxygenase 2Glucaric AcidInterleukin-6PhytochemicalsPtgs2 protein, mouseResveratrolStilbenesTetradecanoylphorbol AcetateTriterpenesUrsolic Acid

Identifiers

PMID23835587
PMCPMC3787890
OpenAlexW2025771146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.